People · Operator
Named in public records as an officer, director or promoter · active 2009–2017 · Biotechnology, Other Health Care, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Neuros Medical, Inc. | — | Biotechnology | Series C | $160.0M | $338.5M | 2017 |
| Avedro Inc | — | Other Health Care | Series C | $158.4M | $571.6M | 2009 |
| Spirox, Inc. | — | Other Health Care | Series C | $98.2M | $1.0B | 2013 |
| Entrigue Surgical Inc | — | Other Health Care | Series A | $18.1M | $80.7M | 2009 |
| Mimosa Medical, Inc. | — | Other | Seed | $2.2M | $8.3M | 2011 |
Anthony J. Natale at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Anthony J. Natale on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Duke Rohlen | 2 | 10 |
| Doug Koo | 2 | 8 |
| Richard B. Emmitt | 2 | 6 |
| Garheng Kong | 1 | 16 |
| Casey Tansey | 1 | 14 |
| Jonathan Silverstein | 1 | 10 |
| Aftab Kherani | 1 | 9 |
| Joyce Erony | 1 | 8 |
| Fouad Azzam | 1 | 8 |
| Reza Zadno | 1 | 7 |
| Doug Cole | 1 | 6 |
| Philip J. Ferneau | 1 | 6 |
| Camille Samuels | 1 | 6 |
| Marc-Andre Marcotte | 1 | 6 |
| Gilbert H. Kliman | 1 | 5 |
| Joseph Mandato | 1 | 5 |
| STACY ENXING SENG | 1 | 5 |
| William Harrington | 1 | 4 |
| Gilbert Kliman | 1 | 4 |
| Anthony Natale | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.